A single-center study of vascular access sites for intravenous ports

被引:19
作者
Wu, Ching-Feng [1 ]
Ko, Po-Jen [1 ]
Wu, Ching-Yang [1 ]
Liu, Yun-Hen [1 ]
Kao, Tsung-Chi [1 ]
Yu, Sheng-Yueh [1 ]
Li, Hao-Jui [1 ]
Hsieh, Hung-Chang [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Tao Yuan 333, Taiwan
关键词
CENTRAL VENOUS ACCESS; ATRIAL CATHETER; CANCER-PATIENTS; COMPLICATIONS; SYSTEM; DEVICES; VEIN;
D O I
10.1007/s00595-013-0610-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study evaluated the use of intravenous ports and provides a guide related to clinical decision making. This study retrospectively reviewed 1505 patients who had received intravenous ports at Chang Gung Memorial Hospital in 2006. The relationships between the complications and entry routes were assessed. The intervention-free periods were also determined and compared. The patients were followed up until June 2010. Of the 1543 procedures performed, 412 were reinterventions to treat complications, most of which corresponded to fewer than 0.1 episodes per 1000 catheter-days; these were not associated with any particular entry route. There was a higher catheter fracture rate when the right subclavian vein was chosen as the entry vessel (p < 0.05). The intervention-free period ranged from 207 to 533 days. The subclavian vein is not recommended for the use of intravenous ports. There is not only a higher risk of iatrogenic pneumothorax or hemothorax using this entry route but also a higher fracture rate, which may be caused by pinch-off syndrome. The greater saphenous vein should only be considered when the patient has superior vena cava syndrome. However, a higher incidence of infection and a lower device survival rate should be expected with this location.
引用
收藏
页码:723 / 731
页数:9
相关论文
共 17 条
[1]   THE PINCH-OFF SIGN - A WARNING OF IMPENDING PROBLEMS WITH PERMANENT SUBCLAVIAN CATHETERS [J].
AITKEN, DR ;
MINTON, JP .
AMERICAN JOURNAL OF SURGERY, 1984, 148 (05) :633-636
[2]  
AUBANIAC R, 1952, PRESSE MED, V60, P1456
[3]   Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life [J].
Bow, EJ ;
Kilpatrick, MG ;
Clinch, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1267-1273
[4]  
BROVIAC JW, 1973, SURG GYNECOL OBSTET, V136, P602
[5]  
Chang Chia-Lo, 2005, Chang Gung Med J, V28, P425
[6]   Evaluation of infectious complications of the implantable venous access system in a general oncologic population [J].
Chang, LL ;
Tsai, JS ;
Huang, SJ ;
Shih, CC .
AMERICAN JOURNAL OF INFECTION CONTROL, 2003, 31 (01) :34-39
[7]   Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients -: single center experience [J].
Charvat, J. ;
Linke, Z. ;
Horaekova, M. ;
Prausova, J. .
SUPPORTIVE CARE IN CANCER, 2006, 14 (11) :1162-1165
[8]  
Collin GR, 1997, AM SURGEON, V63, P322
[9]   COMPLICATIONS OF INDWELLING VENOUS ACCESS DEVICES IN CANCER-PATIENTS [J].
EASTRIDGE, BJ ;
LEFOR, AT .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :233-238
[10]  
HICKMAN RO, 1979, SURG GYNECOL OBSTET, V148, P871